ReviewDiscover oncology2025

Targeting obesity, metabolic syndrome, and prostate cancer: GLP-1 agonists as emerging therapeutic agents.

Azura Murphy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.